Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Magnetic Resonance in Medicine|December 1, 1987
19F magnetic resonance imaging of the reticuloendothelial systemA V Ratner, R Hurd, H H Muller, et al.Radiology|June 1, 1994
Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trialR F Mattrey, M A Trambert, J J Brown, et al.Photochemistry and Photobiology|June 1, 1996
Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizerS W Young, K W Woodburn, M Wright, et al.Archives of Orthopaedic and Trauma Surgery|July 2, 2018
Outcome of kinematic alignment using patient-specific instrumentation versus mechanical alignment in TKA: a meta-analysis and subgroup analysis of randomised trialsJ T K Woon, I S L Zeng, T Calliess, et al.Journal of Magnetic Resonance Imaging : JMRI|September 1, 1995
Gadolinium zeolite as an oral contrast agent for magnetic resonance imagingS W Young, F Qing, D Rubin, et al.Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRIS W Young, F Qing, A Harriman, et al.Investigative Radiology|March 1, 1994
Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imagingS W Young, M K Sidhu, F Qing, et al.Journal of Magnetic Resonance Imaging : JMRI|May 1, 1994
Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weightT S Desser, D L Rubin, H H Muller, et al.Journal of Clinical Laser Medicine & Surgery|October 1, 1996
Phototherapy of cancer and atheromatous plaque with texaphyrinsK W Woodburn, Q Fan, D Kessel, et al.Journal of Magnetic Resonance Imaging : JMRI|October 6, 1997
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRID L Rubin, K L Falk, M J Sperling, et al.Pageof 10